| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 4-Jan-09 | | Total Revenue | 836,600 | 1,019,400 | 1,122,200 | 1,384,700 | | Cost of Revenue | 350,500 | 458,400 | 531,500 | 702,400 | | | Gross Profit | 486,100 | 561,000 | 590,700 | 682,300 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 461,700 | 528,700 | 505,800 | 551,400 | | Non Recurring |
-
|
-
|
-
| 435,000 | | Others | 34,600 | 33,800 | 34,800 | 37,300 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (10,200) | (1,500) | 50,100 | (341,400) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (31,900) | (5,200) | 600 | 9,800 | | Earnings Before Interest And Taxes | (42,100) | (6,700) | 50,700 | (331,600) | | Interest Expense | 31,900 | 28,800 | 17,400 | 17,500 | | Income Before Tax | (74,000) | (35,500) | 33,300 | (349,100) | | Income Tax Expense | 2,800 | 1,400 | 5,600 | 10,700 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (76,800) | (36,900) | 27,700 | (359,800) | | | Non-recurring Events | | Discontinued Operations | (37,300) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (114,100) | (36,900) | 27,700 | (359,800) | | Preferred Stock And Other Adjustments | (2,700) | (2,800) | (2,800) | (2,900) | | | Net Income Applicable To Common Shares | ($116,800) | ($39,700) | $24,900 | ($362,700) |
|
1.48% Nasdaq 
Income Statement
